Preprint study renews cancer fears for CRISPR-based therapies

Another preprint paper has investors questioning whether CRISPR causes cancer

CRISPR therapeutics companies have been quick to bounce back from each of the gene editing technology’s safety concerns originating from preprint publications in the past two and a half years, but a new paper adds validation to claims that CRISPR-Cas9 may cause cancer.

Although CRISPR is

Read the full 454 word article

User Sign In